Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study.
Shunsuke YokotaKoichi KameiShuichiro FujinagaRiku HamadaAya InabaKentaro NishiMai SatoMasao OguraKoji SakurayaShuichi ItoPublished in: Pediatric nephrology (Berlin, Germany) (2024)
Early administration of rituximab in combination with MPT and immunosuppressants might achieve favorable outcomes in patients with SRNS.